Data protection Impressum

Life sciences

Geneva's University Hospitals (HUG) are launching a dedicated Women's Cardiovascular Health Center to address the underdiagnosis of heart disease in women.

Geneva’s HUG launches a dedicated cardiovascular health center for women

9 March 2026

Bracco Imaging, Limula, and the University of Fribourg have launched an Innosuisse-funded research partnership to automate and reduce the cost of CAR-T cell therapy production.

Bracco, Limula and the University of Fribourg join forces to lower the cost of cell therapies

3 March 2026

Geneva-based Clee Medical has raised Seed funding to accelerate clinical validation of its Neuro Access imaging technology for minimally invasive neurosurgery.

Clee Medical secures financing to advance real-time brain imaging platform

25 February 2026

The canton of Vaud seeks CHF 207.6 million to deploy a unified digital patient record across CHUV and regional hospitals.

The canton of Vaud commits over CHF 200 million to next-generation digital patient record

18 February 2026

Scientists at the University of Fribourg have identified a molecular mechanism that keeps certain breast cancer cells dormant by stimulating the immune response, opening new therapeutic perspectives.

Fribourg researchers identify breast cancer dormancy mechanism

11 February 2026

HemostOD has been awarded a CHF 2 million Innosuisse grant to support the preclinical development of its donor-free, off-the-shelf human blood platelets for transfusion.

HemostOD secures CHF 2 million to advance donor-free platelet development

9 February 2026

SamanTree Medical has secured EUR 20 million from the European Investment Bank to expand its surgical imaging technology across Europe and the United States and accelerate product development.

SamanTree Medical secures EUR 20 million to scale surgical imaging technology

2 February 2026

ORamaVR has raised USD 4.5 million in late-seed funding to accelerate the commercial rollout of its AI-powered medical extended reality platform for surgical training and device simulation.

Geneva-based ORamaVR raises USD 4.5 million to scale medical XR training solutions

30 January 2026

The Fonds pour l’Innovation et le Futur de Genève (FIF) has awarded CHF 50,000 grants to three academic spin-off projects from Geneva, supporting innovation in medical technology, scientific instrumentation, and gene therapy.

FIF awards grants to three Geneva-based academic spin-offs

29 January 2026

Researchers from the Francis Crick Institute and Bern-based AlveoliX have developed the first human lung-on-chip model built entirely from genetically identical cells, opening new perspectives for personalised respiratory disease research.

AlveoliX contributes to first lung-on-chip model using genetically identical human cells

19 January 2026

1 2 3 4 5 6 … 48